Effect of angiopoietin-like protein 4 on rat pulmonary microvascular endothelial cells exposed to LPS

International Journal of Molecular Medicine

Volumn 32, Issue 3, 2013, Pages 568-576

  Wang, Yuxi ^a   Chen, Hailong ^a   Li, Hailong ^a,c   Zhang, Jingwen ^a   Gao, Yanyan ^b  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b DALIAN MUNICIPAL CENTRAL HOSPITAL   (China)

^c UNIVERSITY OF MISSOURI   (United States)

Author keywords

Acute lung injury; Angiopoietin like protein 4; F actin; Pulmonary microvascular endothelial cell

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN LIKE PROTEIN 4; CASPASE 8; CASPASE 9; COMPLEMENTARY DNA; CYTOKINE; LIPOPOLYSACCHARIDE; PROTEIN BAX; ROSIGLITAZONE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL STRUCTURE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; MALE; METASTASIS; MICROVASCULAR ENDOTHELIAL CELL; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ACUTE LUNG INJURY; ANGIOPOIETINS; ANIMALS; APOPTOSIS; CAPILLARY PERMEABILITY; CELL SURVIVAL; ENDOTHELIAL CELLS; GENE EXPRESSION; LIPOPOLYSACCHARIDES; LUNG; MICROVESSELS; PRIMARY CELL CULTURE; RATS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84880411598     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1420     Document Type: Article

References (41)

1. Ge H, Yang G, Yu X, Pourbahrami T and Li C: Oligomerization state-dependent hyperlipidemic effect of angiopoietin-like protein 4. J Lipid Res 45: 2071-2079, 2004.
2. Xu A, Lam MC, Chan KW, et al: Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice. Proc Natl Acad Sci USA 102: 6086-6091, 2005.
3. Sukonina V, Lookene A, Olivecrona T and Olivecrona G: Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue. Proc Natl Acad Sci USA 103: 17450-17455, 2006.
4. Mandard S, Zandbergen F, van Straten E, Wahli W, Kuipers F, Muller M and Kersten S: The fasting-induced adipose factor/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. J Biol Chem 281: 934-944, 2006.
5. Zhu P, Tan MJ, Huang RL, et al: Angiopoietin-like 4 protein elevates the prosurvival intracellular O2(-):H2O2 ratio and confers anoikis resistance to tumors. Cancer Cell 19: 401-415, 2011.
6. Kersten S: Regulation of lipid metabolism via angiopoietin-like proteins. Biochem Soc Trans 33:1059-1062, 2005.
7. Mandard S, Zandbergen F, Tan NS, et al: The direct peroxisome proliferator-activated receptor target fasting-induced adipose factor (FIAF/PGAR/ANGPTL4) is present in blood plasma as a truncated protein that is increased by fenofibrate treatment. J Biol Chem 279: 34411-34420, 2004.
8. Koliwad SK, Kuo T, Shipp LE, et al: Angiopoietin-like 4 (ANGPTL4, fasting-induced adipose factor) is a direct glucocorticoid receptor target and participates in glucocorticoid-regulated triglyceride metabolism. J Biol Chem 284: 25593-25601, 2009.
9. Padua D, Zhang XH, Wang Q, et al: TGF beta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell 133: 66-77, 2008.
10. Belanger AJ, Lu H, Date T, et al: Hypoxia up-regulates expression of peroxisome proliferator-activated receptor gamma angiopoietin-related gene (PGAR) in cardiomyocytes: role of hypoxia inducible factor 1alpha. J Mol Cell Cardiol 34: 765-774, 2002
11. Liu F, Li W, Pauluhn J, Trubel H and Wang C: Lipopolysaccharide-induced acute lung injury in rats: comparative assessment of intratracheal instillation and aerosol inhalation. Toxicology 304: 158-166, 2013.
12. Feingold KR, Shigenaga JK, Cross AS, Moser A and Grunfeld C: Angiopoietin like protein 4 expression is decreased in activated macrophages. Biochem Biophys Res Commun 421: 612-615, 2012.
13. Ichikawa H, Naito Y, Takagi T, et al: A specific peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligand, pioglitazone, ameliorates gastric mucosal damage induced by ischemia and reperfusion in rats. Redox Rep 7: 343-346, 2002.
14. Konturek PC, Brzozowski T, Kania J, et al: Pioglitazone, a specific ligand of the peroxisome proliferator-activated receptor gamma reduces gastric mucosal injury induced by ischaemia/reperfusion in rat. Scand J Gastroenterol 38: 468-476, 2003.
15. Villegas I, Martin AR, Toma W and de la Lastra CA: Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, protects against gastric ischemia-reperfusion damage in rats: role of oxygen free radicals generation. Eur J Pharmacol 505: 195-203, 2004.
16. Wada K, Nakajima A, Takahashi H, et al: Protective effect of endogenous PPARgamma against acute gastric mucosal lesions associated with ischemia-reperfusion. Am J Physiol Gastrointest Liver Physiol 287: G452-G458, 2004.
17. Takagi T, Naito Y, Ichikawa H, et al: A PPAR-gamma ligand, 15-deoxy-Delta12,14-prostaglandin J(2), inhibited gastric mucosal injury induced by ischemia-reperfusion in rats. Redox Rep 9: 376-381, 2004.
18. Naito Y, Takagi T, Matsuyama K, Yoshida N and Yoshikawa T: Pioglitazone, a specific PPAR-gamma ligand, inhibits aspirin-induced gastric mucosal injury in rats. Aliment Pharmacol Ther 15: 865-873, 2001.
19. Slomiany A, Nishikawa H and Slomiany BL: Screening and modulation of extracellular signals by mucous barrier. Serum glycosylphosphatidylinositol phospholipase D (GPI-PLD) releases protective mucous barrier from oral mucosa. J Physiol Pharmacol 53: 21-38, 2002.
20. Lappas M, Permezel M and Rice GE: 15-Deoxy-Delta(12,14)-prostaglandin J(2) and troglitazone regulation of the release of phospholipid metabolites, inflammatory cytokines and proteases from human gestational tissues. Placenta 27: 1060-1072, 2006.
21. Chen SF, Fei X and Li SH: A new simple method for isolation of microvascular endothelial cells avoiding both chemical and mechanical injuries. Microvasc Res 50: 119-128, 1995.
22. Cheng C, Liu H, Ge H, et al: Lipopolysaccharide induces expression of SSeCKS in rat lung microvascular endothelial cell. Mol Cell Biochem 305: 1-8, 2007.
23. Zhang H and Sun GY: LPS induces permeability injury in lung microvascular endothelium via AT(1) receptor. Arch Biochem Biophys 441: 75-83, 2005.
24. Adkison JB, Miller GT, Weber DS, et al: Differential responses of pulmonary endothelial phenotypes to cyclical stretch. Microvasc Res 71: 175-184, 2006.
25. Gao G, Kapushoc ST, Simpson AM, Thiemann OH and Simpson L: Guide RNAs of the recently isolated LEM125 strain of Leishmania tarentolae: an unexpected complexity. RNA 7: 1335-1347, 2001.
26. Essler M, Staddon JM, Weber PC and Aepfelbacher M: Cyclic AMP blocks bacterial lipopolysaccharide-induced myosin light chain phosphorylation in endothelial cells through inhibition of Rho/Rho kinase signaling. J Immunol 164: 6543-6549, 2000.
27. Harhaj NS and Antonetti DA: Regulation of tight junctions and loss of barrier function in pathophysiology. Int J Biochem Cell Biol 36: 1206-1237, 2004.
28. Koishi R, Ando Y, Ono M, et al: Angptl3 regulates lipid metabolism in mice. Nat Genet 30: 151-157, 2002.
29. Oike Y, Yasunaga K, Ito Y, et al: Angiopoietin-related growth factor (AGF) promotes epidermal proliferation, remodeling, and regeneration. Proc Natl Acad Sci USA 100: 9494-9499, 2003.
30. Kim I, Kim HG, Kim H, et al: Hepatic expression, synthesis and secretion of a novel fibrinogen/angiopoietin-related protein that prevents endothelial-cell apoptosis. Biochem J 346: 603-610, 2000.
31. Brunckhorst MK, Wang H, Lu R, et al: Angiopoietin-4 promotes glioblastoma progression by enhancing tumor cell viability and angiogenesis. Cancer Res 70: 7283-7293, 2010.
32. Lu B, Moser A, Shigenaga JK, Grunfeld C and Feingold KR: The acute phase response stimulates the expression of angiopoietin like protein 4. Biochem Biophys Res Commun 391: 1737-1741, 2010.
33. Hermann LM, Pinkerton M, Jennings K, et al: Angiopoietin-like-4 is a potential angiogenic mediator in arthritis. Clin Immunol 115: 93-101, 2005.
34. Cazes A, Galaup A, Chomel C et al: Extracellular matrix-bound angiopoietin-like 4 inhibits endothelial cell adhesion, migration, and sprouting and alters actin cytoskeleton. Circ Res 99: 1207-1215, 2006.
35. Yang YH, Wang Y, Lam KS, et al: Suppression of the Raf/MEK/ERK signaling cascade and inhibition of angiogenesis by the carboxyl terminus of angiopoietin-like protein 4. Arterioscler Thromb Vasc Biol 28: 835-840, 2008.
36. Galaup A, Cazes A, Le Jan S, et al: Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasiveness. Proc Natl Acad Sci USA 103: 18721-18726, 2006.
37. Li KQ, Li WL, Peng SY, et al: Anti-tumor effect of recombinant retroviral vector-mediated human ANGPTL4 gene transfection. Chin Med J (Engl) 117: 1364-1369, 2004.
38. Dhillon AS and Kolch W: Untying the regulation of the Raf-1 kinase. Arch Biochem Biophys 404: 3-9, 2002.
39. Wu F, Wang H, Li J, Liang J and Ma S: Homoplantaginin modulates insulin sensitivity in endothelial cells by inhibiting inflammation. Biol Pharm Bull 35: 1171-1177, 2012.
40. Masamune A, Watanabe T, Kikuta K and Shimosegawa T: Roles of pancreatic stellate cells in pancreatic inflammation and fibrosis. Clin Gastroenterol Hepatol 7: S48-S54, 2009.
41. Faulkner A, Rosen S and Norman C: The right information may matter more than frequency-place alignment: simulations of frequency-aligned and upward shifting cochlear implant processors for a shallow electrode array insertion. Ear Hear 27: 139-152, 2006.